MEDBOT-B Receives CSRC Filing Notice for H-Share Full Circulation Application

Stock News02-04 23:08

MEDBOT-B (02252) has announced that the company recently received an official filing notice from the China Securities Regulatory Commission regarding its application for H-share full circulation. This signifies that the company has completed the CSRC filing process for the conversion of a total of 5,989,800 non-listed shares, held by two of its shareholders, into 5,989,800 H-shares on a one-for-one basis. These 5,989,800 H-shares will be listed and traded on the Main Board of The Stock Exchange of Hong Kong following the completion of the conversion process and the granting of listing approval by the Exchange. The notice remains valid for a period of 12 months from the date of approval by the CSRC.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment